Adding medical cannabis to fibromyalgia treatment improved sleep and reduced other pain medications | Research

The takeaway

In 102 fibromyalgia patients who added medical cannabis to their existing pain treatment, 44% showed significant sleep improvement, 33% had meaningful overall symptom improvement, and 47% reduced or stopped other pain medications over 6 months.

Fibromyalgia patients, rheumatologists, and pain management specialists.

47% reduced or stopped other pain medications

What the researchers found

Medical cannabis most consistently improved sleep quality (44% of patients) and overall fibromyalgia impact (33%). Half of patients showed moderate improvement in anxiety and depression. Nearly half reduced or stopped concomitant analgesic treatment. Lower BMI correlated with better outcomes.

Why it matters

Fibromyalgia is difficult to treat, and many patients have inadequate pain relief. The finding that medical cannabis allowed nearly half to reduce other medications suggests it may not just add benefit but could simplify treatment regimens.

The numbers in context

102 patients enrolled. 64% retention at 6 months. 44% improved sleep (PSQI). 33% improved overall (FIQR). 50% moderate anxiety/depression improvement. 47% reduced or stopped other analgesics. BMI correlated with outcomes (p=0.017).

How the study worked

Prospective observational study of 102 consecutive fibromyalgia patients with VAS pain scores of 4 or higher despite existing treatment. Patients received oil-diluted cannabis extracts (Bedrocan: 22% THC, <1% CBD; or Bediol: 6.3% THC, 8% CBD) for 6 months.

What this study cannot tell us

No control group or blinding, so placebo effects cannot be ruled out. Self-selected patient population. Two different cannabis formulations were used, making it difficult to determine which is more effective.

How to read the evidence

Moderate: prospective design with 102 patients, though limited by lack of control group and blinding.

When this study was published

Published in 2020 in Clinical and Experimental Rheumatology.

The bigger picture

The 64% retention rate and medication reduction data suggest medical cannabis provided enough benefit for most patients to continue, though about one-third experienced mild adverse events.

Questions still open

Which cannabis formulation (high-THC vs. balanced THC:CBD) works better for fibromyalgia? Why did lower BMI predict better outcomes? Would a controlled trial confirm these observational findings?

Common questions

Did cannabis replace other pain medications?

In 47% of patients, concomitant analgesic treatment was either reduced or stopped entirely during the 6-month study period, suggesting medical cannabis provided sufficient relief to replace some existing treatments.

What was the most improved symptom?

Sleep quality showed the most consistent improvement, with 44% of patients showing significant gains. This aligns with other studies suggesting cannabis may be particularly helpful for sleep-related symptoms in chronic pain conditions.

Read the original research

Adding medical cannabis to standard analgesic treatment for fibromyalgia: a prospective observational study.

Clinical and experimental rheumatology, 38 Suppl 123(1), 53-59

View on PubMed ↗

Citation

Giorgi, Valeria; Bongiovanni, Sara; Atzeni, Fabiola; Marotto, Daniela; Salaffi, Fausto; Sarzi-Puttini, Piercarlo. (2020). Adding medical cannabis to standard analgesic treatment for fibromyalgia: a prospective observational study.. Clinical and experimental rheumatology, 38 Suppl 123(1), 53-59.